QLT, Inc. (QLTI) Reports Publication of Clinically Meaningful QLT091001 Phase 1b Data
Tweet Send to a Friend
QLT, Inc. (Nasdaq: QLTI) announced the publication of data from its Phase 1b proof-of-concept trial of QLT091001 in subjects with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
